National Study to Examine Risks, Benefits in Emergent Whole Genome Sequencing
<p>Improving technologies are rapidly cutting the cost of whole genome sequencing, a process that reveals the complete library of a patient’s genetic information. UCSF School of Pharmacy's Kathryn Phillips, PhD, will lead the first national study to analyze how physicians and patients evaluate the benefits and risks posed by this profusion of information.</p>
